ANTIMICROBIAL-RESISTANT ENTEROCOCCAL ISOLATES FROM FLURROQUINOLONE-NAIVE CHILDREN

This publication has 7 references indexed in Scilit:

• The Use of Avoparcin as a Growth Promoter and the Occurrence of Vancomycin-ResistantEnterococcusSpecies in Norwegian Poultry and Swine Production
  Microbial Drug Resistance, 1999
• Antibiotic‐Selective Environments
  Clinical Infectious Diseases, 1998
• An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center
  The Pediatric Infectious Disease Journal, 1998
• Diversity among Multidrug-Resistant Enterococci
  Emerging Infectious Diseases, 1998
• In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
  Journal of Antimicrobial Chemotherapy, 1997
• Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria
  Journal of Antimicrobial Chemotherapy, 1997
• Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens
  The Pediatric Infectious Disease Journal, 1996